This is a non-core endpoint: only basic statistics are computed.
Acrodermatitis chronica atrophicans
DOID EFO MESH SNOMED Endpoint Browser
L12_ACRODERMATITIS
acrodermatitis chronica atrophicans: An acrodermatitis characterized by a chronically progressive course, leading to widespread atrophy of the skin. It is a clinical manifestation of Lyme borreliosis.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
L90.4
Hospital discharge: ICD-9
7018C
Hospital discharge: ICD-8
70190
Cause of death: ICD-10
L90.4
Cause of death: ICD-9
7018C
Cause of death: ICD-8
70190
2 out of 7 registries used, show all original rules.
35
Check minimum number of events None
35
Include endpoints None
35
Remove individuals based on genotype QC
34
L12_ACRODERMATITIS
Control definitions
Control exclude
L12_OTHERSKINSUBCUTIS
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L90
Name in latin
Acrodermatitis chronica atrophicans
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Acrodermatitis chronica atrophicans
based on the number of shared cases.
Broader endpoints:
- Atrophic disorders of skin
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 34 | 22 | 12 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 54.25 | 56.58 | 49.97 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: L12_ACRODERMATITIS – Acrodermatitis chronica atrophicans
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Acrodermatitis chronica atrophicans
↥Endpoint not on priority list, no data to show.